Martin Schwarzschild - Publications

Affiliations: 
1947-1997 Astronomy Princeton University, Princeton, NJ 
Area:
Astrophysics
Website:
http://www.phys-astro.sonoma.edu/brucemedalists//Schwarzschild/Schwarzschild.html

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chen JF, Schwarzschild MA. Do caffeine and more selective adenosine A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease? Parkinsonism & Related Disorders. 45-53. PMID 33349580 DOI: 10.1016/j.parkreldis.2020.10.024  0.332
2020 Simuni T, Fiske B, Merchant K, Coffey CS, Klingner E, Caspell-Garcia C, Lafontant DE, Matthews H, Wyse RK, Brundin P, Simon DK, Schwarzschild M, Weiner D, Adams J, Venuto C, et al. Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial. Jama Neurology. PMID 33315105 DOI: 10.1001/jamaneurol.2020.4725  0.301
2020 Hasimoglu YG, Chen X, Bakshi R, Schwarzschild MA, Macklin EA. Does Serum Urate Change as Parkinson's Disease Progresses? Journal of Parkinson's Disease. 10: 1571-1576. PMID 32773396 DOI: 10.3233/Jpd-202064  0.306
2020 Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, et al. Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? Neurology. PMID 32102975 DOI: 10.1212/Wnl.0000000000009107  0.305
2018 Iwaki H, Hughes KC, Gao X, Schwarzschild MA, Ascherio A. The association between restless legs syndrome and premotor symptoms of Parkinson's disease. Journal of the Neurological Sciences. 394: 41-44. PMID 30212740 DOI: 10.1016/J.Jns.2018.08.028  0.3
2018 Hughes KC, Gao X, O'Reilly EJ, Kim IY, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A. Genetic variants related to urate and risk of Parkinson's disease. Parkinsonism & Related Disorders. PMID 29789205 DOI: 10.1016/J.Parkreldis.2018.04.031  0.315
2018 Kim IY, O'Reilly ÉJ, Hughes KC, Gao X, Schwarzschild MA, Hannan MT, Betensky RA, Ascherio A. Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts. Neurology. PMID 29643081 DOI: 10.1212/Wnl.0000000000005473  0.311
2017 Crotty GF, Ascherio A, Schwarzschild MA. Targeting urate to reduce oxidative stress in Parkinson disease. Experimental Neurology. 298: 210-224. PMID 28622913 DOI: 10.1016/J.Expneurol.2017.06.017  0.311
2017 Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, et al. Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28233927 DOI: 10.1002/Mds.26913  0.315
2016 Paganoni S, Schwarzschild MA. Urate as a Marker of Risk and Progression of Neurodegenerative Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 27995438 DOI: 10.1007/S13311-016-0497-4  0.32
2016 Gao X, O'Reilly ÉJ, Schwarzschild MA, Ascherio A. Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology. PMID 26764029 DOI: 10.1212/Wnl.0000000000002351  0.314
2014 Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A. Mendelian randomization of serum urate and parkinson disease progression. Annals of Neurology. 76: 862-8. PMID 25257975 DOI: 10.1002/Ana.24281  0.3
2013 Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, ... Schwarzschild MA, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 81: 1531-7. PMID 24068787 DOI: 10.1212/Wnl.0B013E3182A95818  0.313
2012 Chen X, Wu G, Schwarzschild MA. Urate in Parkinson's disease: more than a biomarker? Current Neurology and Neuroscience Reports. 12: 367-75. PMID 22580741 DOI: 10.1007/S11910-012-0282-7  0.333
2012 Gao X, Simon KC, Schwarzschild MA, Ascherio A. Prospective study of statin use and risk of Parkinson disease. Archives of Neurology. 69: 380-4. PMID 22410446 DOI: 10.1001/Archneurol.2011.1060  0.308
2010 Cipriani S, Chen X, Schwarzschild MA. Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomarkers in Medicine. 4: 701-12. PMID 20945982 DOI: 10.2217/Bmm.10.94  0.322
2010 Gao X, Schwarzschild MA, O'Reilly EJ, Wang H, Ascherio A. Restless legs syndrome and Parkinson's disease in men. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2654-7. PMID 20737545 DOI: 10.1002/Mds.23256  0.303
2010 Morelli M, Carta AR, Kachroo A, Schwarzschild MA. Pathophysiological roles for purines: adenosine, caffeine and urate. Progress in Brain Research. 183: 183-208. PMID 20696321 DOI: 10.1016/S0079-6123(10)83010-9  0.318
2010 Simon KC, Gao X, Chen H, Schwarzschild MA, Ascherio A. Calcium channel blocker use and risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1818-22. PMID 20669249 DOI: 10.1002/Mds.23191  0.301
2010 Kachroo A, Irizarry MC, Schwarzschild MA. Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration. Experimental Neurology. 223: 657-61. PMID 20188092 DOI: 10.1016/J.Expneurol.2010.02.007  0.303
2009 Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A. Family history of melanoma and Parkinson disease risk. Neurology. 73: 1286-91. PMID 19841380 DOI: 10.1212/Wnl.0B013E3181Bd13A1  0.314
2009 Carta AR, Kachroo A, Schintu N, Xu K, Schwarzschild MA, Wardas J, Morelli M. Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease. Journal of Neurochemistry. 111: 1478-89. PMID 19817968 DOI: 10.1111/J.1471-4159.2009.06425.X  0.309
2009 Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P, Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston JW, ... Schwarzschild M, et al. Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environmental Health Perspectives. 117: 117-21. PMID 19165397 DOI: 10.1289/Ehp.11702  0.302
2008 Gao X, Chen H, Choi HK, Curhan G, Schwarzschild MA, Ascherio A. Diet, urate, and Parkinson's disease risk in men. American Journal of Epidemiology. 167: 831-8. PMID 18326873 DOI: 10.1093/Aje/Kwm385  0.307
2008 Gao X, Chen H, Schwarzschild MA, Logroscino G, Ascherio A. Perceived imbalance and risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 613-6. PMID 18181208 DOI: 10.1002/Mds.21919  0.323
2007 Weisskopf MG, O'Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson's disease. American Journal of Epidemiology. 166: 561-7. PMID 17584757 DOI: 10.1093/Aje/Kwm127  0.303
2007 Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR. Molecular markers of early Parkinson's disease based on gene expression in blood. Proceedings of the National Academy of Sciences of the United States of America. 104: 955-60. PMID 17215369 DOI: 10.1073/Pnas.0610204104  0.304
2006 Ascherio A, Chen H, Weisskopf MG, O'Reilly E, McCullough ML, Calle EE, Schwarzschild MA, Thun MJ. Pesticide exposure and risk for Parkinson's disease. Annals of Neurology. 60: 197-203. PMID 16802290 DOI: 10.1002/Ana.20904  0.302
2006 Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1002-7. PMID 16602107 DOI: 10.1002/Mds.20881  0.316
2005 Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Annals of Neurology. 58: 963-7. PMID 16240369 DOI: 10.1002/Ana.20682  0.303
2005 Hauser RA, Schwarzschild MA. Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience. Drugs & Aging. 22: 471-482. PMID 15974638 DOI: 10.2165/00002512-200522060-00002  0.33
2005 Xu K, Bastia E, Schwarzschild M. Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease. Pharmacology & Therapeutics. 105: 267-310. PMID 15737407 DOI: 10.1016/J.Pharmthera.2004.10.007  0.322
2003 Schwarzschild MA, Xu K, Oztas E, Petzer JP, Castagnoli K, Castagnoli N, Chen JF. Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease. Neurology. 61: S55-61. PMID 14663012 DOI: 10.1212/01.Wnl.0000095214.53646.72  0.307
2003 Chen H, Zhang SM, Hernán MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE, Ascherio A. Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease Jama Neurology. 60: 1059-1064. PMID 12925360 DOI: 10.1001/Archneur.60.8.1059  0.315
2002 Schwarzschild MA, Chen J, Ascherio A. Caffeinated clues and the promise of adenosine A2A antagonists in PD Neurology. 58: 1154-1160. PMID 11971080 DOI: 10.1212/Wnl.58.8.1154  0.33
2001 Chen J, Xu K, Petzer JP, Staal R, Xu Y, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N, Schwarzschild MA. Neuroprotection by Caffeine and A2AAdenosine Receptor Inactivation in a Model of Parkinson's Disease The Journal of Neuroscience. 21: RC143-RC143. DOI: 10.1523/Jneurosci.21-10-J0001.2001  0.307
1977 Schwarzschild M, Spitzer L. Robert E. Danielson (1931–1976) Icarus. 30: 601-603. DOI: 10.1016/0019-1035(77)90114-2  0.533
1951 Spitzer L, Schwarzschild M. The Possible Influence of Interstellar Clouds on Stellar Velocities. II. The Astrophysical Journal. 118: 106. DOI: 10.1086/145730  0.533
1949 Hen L, Schwarzschild M, Spitzer L. Red-Giant Models with Chemical Inhomogeneities Monthly Notices of the Royal Astronomical Society. 109: 631-646. DOI: 10.1093/Mnras/109.6.631  0.533
Show low-probability matches.